Ally Bridge Group (NY) LLC Quant / Systematic

CIK: 0001822947 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $102,791 (100.0% shares, 0.0% debt)

Holdings (30)

RARE ULTRAGENYX PHARMACEUTICAL IN 8.4%
Value ($000) $8,583 Shares 185,261 Est. Cost $51.39 Unrealized -23.5%
WHWK AADI BIOSCIENCE INC 7.9%
Value ($000) $8,121 Shares 632,997 Est. Cost $13.07 Unrealized -0.1%
ACAD ACADIA PHARMACEUTICALS INC 7.4%
Value ($000) $7,558 Shares 474,741 Est. Cost $15.63 Unrealized 0.0%
MERSANA THERAPEUTICS INC 6.8%
Value ($000) $6,981 Shares 1,191,271 Est. Cost $6.56 Unrealized
GLPG GALAPAGOS NV 6.0%
Value ($000) $6,216 Shares 140,054 Est. Cost $43.43 Unrealized
ALLAKOS INC 5.1%
Value ($000) $5,240 Shares 622,364 Est. Cost $6.21 Unrealized
SEAGEN INC 4.7%
Value ($000) $4,837 Shares 37,639 Est. Cost $136.83 Unrealized
AVIR ATEA PHARMACEUTICALS INC 4.5%
Value ($000) $4,631 Shares 962,694 Est. Cost $6.03 Unrealized -16.1%
SAGE THERAPEUTICS INC 4.4%
Value ($000) $4,539 Shares 119,008 Est. Cost $39.08 Unrealized
AMARIN CORP PLC 4.4%
Value ($000) $4,514 Shares 3,730,859 Est. Cost $1.09 Unrealized
IRWD IRONWOOD PHARMACEUTICALS INC 3.9%
Value ($000) $4,044 Shares 326,428 Est. Cost $11.34 Unrealized +0.1%
SANA SANA BIOTECHNOLOGY INC 3.9%
Value ($000) $4,010 Shares 1,015,273 Est. Cost $6.58 Unrealized -25.6%
ALKS ALKERMES PLC 3.6%
Value ($000) $3,711 Shares 142,002 Est. Cost $26.01 Unrealized -8.0%
SYRS SYROS PHARMACEUTICALS INC 3.0%
Value ($000) $3,118 Shares 868,403 Est. Cost $8.12 Unrealized -46.6%
KARYOPHARM THERAPEUTICS INC 3.0%
Value ($000) $3,049 Shares 896,618 Est. Cost $5.46 Unrealized
NEKTAR THERAPEUTICS 2.9%
Value ($000) $3,016 Shares 1,334,661 Est. Cost $2.56 Unrealized
SELECTA BIOSCIENCES INC 2.8%
Value ($000) $2,891 Shares 2,558,474 Est. Cost $1.20 Unrealized
BHVN BIOHAVEN LTD 2.4%
Value ($000) $2,486 Shares 179,085 Est. Cost $14.12 Unrealized 0.0%
RCKT ROCKET PHARMACEUTICALS INC 2.4%
Value ($000) $2,450 Shares 125,176 Est. Cost $15.60 Unrealized +18.0%
MIRATI THERAPEUTICS INC 2.1%
Value ($000) $2,153 Shares 47,520 Est. Cost $45.31 Unrealized
RGEN REPLIGEN CORP 2.0%
Value ($000) $2,062 Shares 12,180 Est. Cost $210.87 Unrealized -14.0%
ESSA PHARMA INC 2.0%
Value ($000) $2,045 Shares 811,555 Est. Cost $2.52 Unrealized
MEDAVAIL HOLDINGS INC 1.7%
Value ($000) $1,767 Shares 5,894,897 Est. Cost $8.23 Unrealized
PRAXIS PRECISION MEDICINES I 1.5%
Value ($000) $1,501 Shares 630,584 Est. Cost $2.38 Unrealized
MORPHOSYS AG 1.4%
Value ($000) $1,452 Shares 405,602 Est. Cost $3.92 Unrealized
RPID RAPID MICRO BIOSYSTEMS INC 0.8%
Value ($000) $791 Shares 699,664 Est. Cost $15.69 Unrealized -84.6%
CURIS INC 0.4%
Value ($000) $455 Shares 827,397 Est. Cost $0.60 Unrealized
NAUT NAUTILUS BIOTECHNOLOGY INC 0.3%
Value ($000) $287 Shares 159,232 Est. Cost $10.83 Unrealized -82.2%
SCIENCE 37 HOLDINGS INC 0.2%
Value ($000) $160 Shares 384,397 Est. Cost $2.01 Unrealized
DNLI DENALI THERAPEUTICS INC 0.1%
Value ($000) $125 Shares 4,479 Est. Cost $29.75 Unrealized 0.0%